About this trial
This randomized, sham-controlled crossover trial aims to evaluate the immediate effects of spinal manipulation on heart rate variability in children with cerebral palsy. Each participant will attend four experimental sessions conducted on separate days. In two sessions, spinal manipulation will be performed, and in two sessions, a sham procedure will be applied. The order of interventions will be randomized for each participant. Heart rate variability will be recorded before and after each intervention.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Cerebral palsy
Motor function levels I-III according to GMFCS
Cooperative behavior
Disqualifiers
Hyperkinetic forms
Use of medications affecting autonomic regulation
Trial design
Crossover
Treatments tested in this trial
Spinal manipulation
Procedure/SurgeryA high-velocity, low-amplitude (HVLA) spinal manipulation will be delivered to the cervical, thoracic and lumbar regions of the spine with the participant in a standardized position. The procedure will be performed by a licensed practitioner experienced in pediatric care. Each session will last approximately the same duration as the sham procedure.
Sham Procedure
Other interventionThe sham procedure will involve light manual contact and positioning similar to spinal manipulation but without the application of high-velocity, low-amplitude thrust or joint cavitation. This procedure is designed to control for tactile and contextual effects of the intervention while minimizing physiological impact. The duration and environment will match those of the active intervention sessions.
Treatment groups
Trial outcomes
Primary outcomes
Root Mean Square of Successive Differences (RMSSD)
RMSSD will be calculated from short-term heart rate variability recordings obtained under standardized resting conditions. It reflects parasympathetic (vagal) modulation of heart rate. The primary outcome is the change in RMSSD from pre- to post-intervention within each session, comparing spinal manipulation and sham conditions.
Secondary outcomes
Standard Deviation of Normal-to-Normal Intervals (SDNN)
SDNN will be derived from heart rate variability recordings and represents overall variability in heart rate, reflecting combined sympathetic and parasympathetic influences. The outcome will be the change in SDNN from pre- to post-intervention within each session.
Heart Rate (HR)
Heart rate will be measured concurrently with heart rate variability recordings under standardized conditions. The outcome will be the change in heart rate from pre- to post-intervention within each session.
Low Frequency/High Frequency Ratio (LF/HF Ratio)
The LF/HF ratio will be calculated from frequency-domain analysis of heart rate variability. It is commonly used as an index of sympathovagal balance. The outcome will be the change in LF/HF ratio from pre- to post-intervention within each session.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
International Clinic of Rehabilitation, Ukraine
Lead sponsor
Elita Rehabilitation Center
Collaborator